Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1994 Dec;49(12):1211–1216. doi: 10.1136/thx.49.12.1211

Airways inflammation in subjects with chronic bronchitis who have never smoked.

M Lusuardi 1, A Capelli 1, C G Cerutti 1, E L Spada 1, C F Donner 1
PMCID: PMC475325  PMID: 7878554

Abstract

BACKGROUND--Smoking is the single most common cause of chronic bronchitis but the disease can also occur in non-smokers. Alterations in the lung responsible for the disease, such as oxidant/antioxidant and protease/antiprotease imbalance, have been investigated in smokers. The aim of our study was to evaluate local cellular and soluble factors (albumin, immunoglobulins, proteases, alpha 1-antitrypsin, and transferrin) that may be involved in the development of chronic bronchitis in subjects who have never smoked. METHODS--Sixteen clinically stable patients with chronic bronchitis who had never been smokers were studied and 17 healthy non-smokers served as controls. All subjects underwent bronchoalveolar lavage (BAL). Total and differential cell counts and concentrations of the main proteins (albumin, immunoglobulins, complement fractions, alpha 1-antitrypsin, and transferrin) were measured. Elastase-like activity was assessed in cells and supernatants. To estimate the oxidant burden the release of superoxide anion (O2-) from native cell populations was evaluated. RESULTS--Recovery of BAL fluid was reduced in older individuals in both the chronic bronchitis and control groups. There was no difference in total cell count, but neutrophil percentage count was higher in those with chronic bronchitis (median (range) 3.5 (1.6-14.2)) than in controls (1.3 (0.5-3.7)). These differences were most pronounced in the first recovery, representative of the bronchial lavage. There was no difference in bronchial epithelial cells. Total proteins and albumin levels were comparable and IgG, IgA, IgM, C3, C4, transferrin and alpha 1-antitrypsin values standardised to albumin did not show any significant differences. No differences in elastase-like levels in supernatants were detected. In cell lysates elastase-like activity x 10(7) cells (macrophages+neutrophils) was increased in patients with chronic bronchitis (0.25 (0.06-4.3) compared with controls 0.08 (0.03-0.9) micrograms PPEeq). The release of O2- both at baseline and after opsonised zymosan phagocytosis did not show any differences. Correlation analysis between FEV1 and BAL fluid data showed a negative correlation only with neutrophils/ml. CONCLUSIONS--Clinically stable non-smokers with chronic bronchitis show no alterations of local immune components, oxidant burden, and free elastase-like activity in BAL fluids, while the content of elastase-like activity in phagocytic cells is increased. As in smokers, bronchial neutrophilia is the most significant cellular modification which correlates with the degree of airflow obstruction.

Full text

PDF
1216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bieth J., Spiess B., Wermuth C. G. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med. 1974 Dec;11(4):350–357. doi: 10.1016/0006-2944(74)90134-3. [DOI] [PubMed] [Google Scholar]
  2. Burnett D., Chamba A., Hill S. L., Stockley R. A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet. 1987 Nov 7;2(8567):1043–1046. doi: 10.1016/s0140-6736(87)91476-0. [DOI] [PubMed] [Google Scholar]
  3. Capelli A., Cerutti C. G., Lusuardi M., Colombo M., Donner C. F. Methods for evaluation of protein components in bronchoalveolar lavage fluids. Clin Chem. 1993 Oct;39(10):2201–2202. [PubMed] [Google Scholar]
  4. Capelli A., Lusuardi M., Carli S., Zaccaria S., Trombetta N., Donner C. F. In vitro effect of beta 2-agonists on bacterial killing and superoxide anion (O2-) release from alveolar macrophages of patients with chronic bronchitis. Chest. 1993 Aug;104(2):481–486. doi: 10.1378/chest.104.2.481. [DOI] [PubMed] [Google Scholar]
  5. Costabel U., Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J. 1992 Jul;5(7):776–779. [PubMed] [Google Scholar]
  6. Davies R. J., Sheinman B. D. Smoking and atmospheric pollution. J Allergy Clin Immunol. 1986 Nov;78(5 Pt 2):1031–1035. doi: 10.1016/0091-6749(86)90299-x. [DOI] [PubMed] [Google Scholar]
  7. Fujita J., Nelson N. L., Daughton D. M., Dobry C. A., Spurzem J. R., Irino S., Rennard S. I. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis. 1990 Jul;142(1):57–62. doi: 10.1164/ajrccm/142.1.57. [DOI] [PubMed] [Google Scholar]
  8. Harris C. C. Tobacco smoke and lung disease: who is susceptible? Ann Intern Med. 1986 Oct;105(4):607–609. doi: 10.7326/0003-4819-105-4-607. [DOI] [PubMed] [Google Scholar]
  9. Hobson J. E., Wright J. L., Wiggs B. R., Hogg J. C. Comparison of the cell content of lung lavage fluid with the presence of emphysema and peripheral airways inflammation in resected lungs. Respiration. 1986;50(1):1–8. doi: 10.1159/000194900. [DOI] [PubMed] [Google Scholar]
  10. Hunninghake G. W., Crystal R. G. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis. 1983 Nov;128(5):833–838. doi: 10.1164/arrd.1983.128.5.833. [DOI] [PubMed] [Google Scholar]
  11. Jeffery P. K. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1152–1161. doi: 10.1164/ajrccm/143.5_Pt_1.1152. [DOI] [PubMed] [Google Scholar]
  12. Luisetti M., Meloni F., Ballabio P., Leo G. Role of bronchial and bronchoalveolar lavage in chronic obstructive lung disease. Monaldi Arch Chest Dis. 1993;48(1):54–57. [PubMed] [Google Scholar]
  13. Lusuardi M., Capelli A., Donner C. F. Interaction between drugs and lung immune defences in COPD: local evaluation with bronchoalveolar lavage. Monaldi Arch Chest Dis. 1993 Oct;48(5):411–414. [PubMed] [Google Scholar]
  14. Martin T. R., Raghu G., Maunder R. J., Springmeyer S. C. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1985 Aug;132(2):254–260. doi: 10.1164/arrd.1985.132.2.254. [DOI] [PubMed] [Google Scholar]
  15. Pacht E. R., Davis W. B. Role of transferrin and ceruloplasmin in antioxidant activity of lung epithelial lining fluid. J Appl Physiol (1985) 1988 May;64(5):2092–2099. doi: 10.1152/jappl.1988.64.5.2092. [DOI] [PubMed] [Google Scholar]
  16. Razmus T. F., Williamson G. F., Van Dis M. L. Assessment of the knowledge of graduating American dental students about the panoramic image. Oral Surg Oral Med Oral Pathol. 1993 Sep;76(3):397–402. doi: 10.1016/0030-4220(93)90278-c. [DOI] [PubMed] [Google Scholar]
  17. Robbins R. A., Gossman G. L., Nelson K. J., Koyama S., Thompson A. B., Rennard S. I. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung. Am Rev Respir Dis. 1990 Oct;142(4):763–768. doi: 10.1164/ajrccm/142.4.763. [DOI] [PubMed] [Google Scholar]
  18. Rossi G. A., Pesci A., Zanon P., Olivieri D. Inflammatory changes in the airway lumen and in the bronchial mucosa of patients with chronic bronchitis. Monaldi Arch Chest Dis. 1993 Oct;48(5):399–402. [PubMed] [Google Scholar]
  19. Saetta M., Di Stefano A., Maestrelli P., Ferraresso A., Drigo R., Potena A., Ciaccia A., Fabbri L. M. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993 Feb;147(2):301–306. doi: 10.1164/ajrccm/147.2.301. [DOI] [PubMed] [Google Scholar]
  20. Spada E. L., Tinivella A., Carli S., Zaccaria S., Lusuardi M., Sbaffi A., Donner C. F. Proposal of an easy method to improve routine sputum bacteriology. Respiration. 1989;56(3-4):137–146. doi: 10.1159/000195793. [DOI] [PubMed] [Google Scholar]
  21. Stockley R. A., Burnett D. Bronchoalveolar lavage and the study of proteinases and antiproteinases in the pathogenesis of chronic obstructive lung disease. Monaldi Arch Chest Dis. 1993;48(3):245–253. [PubMed] [Google Scholar]
  22. Thompson A. B., Daughton D., Robbins R. A., Ghafouri M. A., Oehlerking M., Rennard S. I. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 1989 Dec;140(6):1527–1537. doi: 10.1164/ajrccm/140.6.1527. [DOI] [PubMed] [Google Scholar]
  23. Thompson A. B., Mueller M. B., Heires A. J., Bohling T. L., Daughton D., Yancey S. W., Sykes R. S., Rennard S. I. Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis. 1992 Aug;146(2):389–395. doi: 10.1164/ajrccm/146.2.389. [DOI] [PubMed] [Google Scholar]
  24. Vecchiarelli A., Dottorini M., Puliti M., Todisco T., Cenci E., Bistoni F. Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1049–1054. doi: 10.1164/ajrccm/143.5_Pt_1.1049. [DOI] [PubMed] [Google Scholar]
  25. Velluti G., Capelli O., Lusuardi M., Braghiroli A., Pellegrino M., Milanti G., Benedetti L. Bronchoalveolar lavage in the normal lung. First of three parts: protein, enzymatic and ionic features. Respiration. 1983;44(6):403–410. doi: 10.1159/000194577. [DOI] [PubMed] [Google Scholar]
  26. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES